Home › Stocks › KALV › All Fund Holders
KALV — KALVISTA PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 37 · Reported value held: $396.76M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q1 2026 | 3.80M | $76.41M | 0.00% | Add |
| Capital World Investors history | Q1 2026 | 2.81M | $56.54M | 0.01% | Hold |
| Point72 Asset Management history | Q1 2026 | 2.14M | $43.02M | 0.06% | Reduce |
| Vanguard Group history | Q4 2025 | 2.51M | $40.52M | 0.00% | Hold |
| Millennium Management history | Q1 2026 | 1.91M | $38.49M | 0.02% | Reduce |
| Geode Capital Management history | Q1 2026 | 996.24K | $20.06M | 0.00% | Add |
| Franklin Resources history | Q1 2022 | 1.24M | $18.27M | 0.01% | Reduce |
| Goldman Sachs Group history | Q1 2026 | 824.29K | $16.59M | 0.00% | Reduce |
| BNY Mellon history | Q1 2026 | 584.35K | $11.76M | 0.00% | Reduce |
| Bank of America Corp history | Q1 2026 | 555.63K | $11.18M | 0.00% | Add |
| UBS Group AG history | Q1 2026 | 515.65K | $10.38M | 0.00% | Add |
| Morgan Stanley history | Q1 2026 | 439.10K | $8.84M | 0.00% | Reduce |
| Northern Trust Corp history | Q1 2026 | 363.69K | $7.32M | 0.00% | Add |
| Charles Schwab Investment Management history | Q1 2026 | 323.45K | $6.51M | 0.00% | Hold |
| Citigroup Inc history | Q1 2026 | 244.26K | $4.92M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q1 2026 | 187.85K | $3.78M | 0.00% | Add |
| Citadel Advisors history | Q1 2026 | 169.43K | $3.41M | 0.00% | Add |
| Marshall Wace history | Q1 2026 | 162.91K | $3.28M | 0.00% | New |
| Two Sigma Investments history | Q1 2026 | 153.46K | $3.09M | 0.00% | New |
| Renaissance Technologies history | Q4 2025 | 165.15K | $2.67M | 0.00% | New |
| Wellington Management Group history | Q1 2026 | 107.26K | $2.16M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q2 2024 | 131.30K | $1.55M | 0.00% | New |
| Invesco Ltd history | Q1 2026 | 75.28K | $1.52M | 0.00% | Reduce |
| Deutsche Bank AG history | Q1 2026 | 38.86K | $782.19K | 0.00% | Add |
| AQR Capital Management history | Q1 2026 | 37.57K | $756.33K | 0.00% | Add |
| MFS Investment Management history | Q3 2021 | 31.25K | $545.00K | 0.00% | Reduce |
| Wells Fargo & Co history | Q1 2026 | 23.93K | $481.65K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q1 2026 | 19.79K | $398.51K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q4 2025 | 19.45K | $314.18K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q3 2025 | 21.10K | $257.00K | 0.00% | Reduce |
| Balyasny Asset Management history | Q1 2026 | 11.10K | $223.40K | 0.00% | New |
| Janus Henderson Group history | Q1 2026 | 10.90K | $219.53K | 0.00% | Hold |
| Manulife Financial history | Q1 2026 | 10.55K | $212.39K | 0.00% | Reduce |
| Prudential Financial history | Q1 2022 | 11.84K | $174.00K | 0.00% | Reduce |
| Principal Global Investors history | Q1 2024 | 10.23K | $121.38K | 0.00% | Reduce |
| PNC Financial Services history | Q1 2026 | 149 | $3.00K | 0.00% | Add |
| T. Rowe Price Associates history | Q1 2026 | 29.37K | $592 | 0.00% | Add |